Celcuity shares surge after completing recruitment for breast cancer trial

Investing.comMonday, October 20, 2025 at 9:26:28 AM
Celcuity shares surge after completing recruitment for breast cancer trial
Celcuity's shares have seen a significant surge following the successful completion of recruitment for its breast cancer trial. This milestone is crucial as it not only reflects investor confidence but also highlights the company's commitment to advancing cancer treatment. With the trial now underway, there is hope for new breakthroughs in breast cancer therapies, which could ultimately benefit countless patients.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
BriaCell reports encouraging biomarker data in Phase 3 breast cancer study
PositiveFinancial Markets
BriaCell has announced promising biomarker data from its Phase 3 study on breast cancer, which is a significant step forward in cancer research. This data could potentially lead to new treatment options for patients, highlighting the importance of ongoing clinical trials in the fight against cancer.
Where Is Susan Lorincz Now? What Happened To ‘The Perfect Neighbor’ Killer
NeutralFinancial Markets
Netflix's documentary 'The Perfect Neighbor' sheds light on the tragic case of AJ Owens, who was fatally shot by her neighbor, Susan Lorincz. The film revisits the courtroom drama surrounding Lorincz's trial and explores the aftermath of this heartbreaking incident. Understanding this case is crucial as it highlights issues of community safety and the complexities of neighborly relationships, prompting discussions about accountability and justice.
Kelun-Biotech's breast cancer drug shows promising phase 3 results
PositiveFinancial Markets
Kelun-Biotech has announced promising results from its phase 3 trials for a new breast cancer drug, which could significantly improve treatment options for patients. This development is crucial as it highlights advancements in cancer therapies, potentially leading to better outcomes and quality of life for those affected by the disease.
ENHERTU shows 92% invasive disease-free survival rate at three years in breast cancer trial
PositiveFinancial Markets
A recent clinical trial has shown that ENHERTU, a targeted therapy for breast cancer, achieved an impressive 92% invasive disease-free survival rate at three years. This significant result highlights the potential of ENHERTU to improve outcomes for patients battling this challenging disease, offering hope for better treatment options in oncology.
ESMO 2025: enhertu shows highest pCR rate in HER2+ early breast cancer
PositiveFinancial Markets
At the ESMO 2025 conference, the drug Enhertu has demonstrated the highest pathologic complete response (pCR) rate in patients with HER2-positive early breast cancer. This is significant as it highlights a promising advancement in treatment options for a challenging subtype of breast cancer, potentially improving outcomes for many patients.
Gedatolisib shows strong results in breast cancer trial
PositiveFinancial Markets
Gedatolisib has demonstrated promising results in a recent breast cancer trial, showcasing its potential as a new treatment option. This is significant because it could offer hope to patients who have limited choices, highlighting advancements in oncology research and the ongoing fight against breast cancer.
Celcuity reports positive Phase 1 data for prostate cancer therapy
PositiveFinancial Markets
Celcuity has announced promising Phase 1 data for its new prostate cancer therapy, which could significantly improve treatment options for patients. This development is crucial as prostate cancer remains one of the most common cancers among men, and effective therapies are in high demand. The positive results from the clinical trial not only highlight the potential of Celcuity's approach but also bring hope to many who are affected by this disease.
Celcuity completes enrollment for PIK3CA mutant cohort in phase 3 trial
PositiveFinancial Markets
Celcuity has successfully completed enrollment for its PIK3CA mutant cohort in a phase 3 clinical trial, marking a significant milestone in cancer research. This trial aims to evaluate the effectiveness of a new treatment for patients with specific mutations, which could lead to improved outcomes and options for those affected by this type of cancer. The completion of enrollment is a crucial step towards potentially bringing innovative therapies to market.
Latest from Financial Markets
Amazon says cloud services recovering from widespread outage
PositiveFinancial Markets
Amazon has announced that its cloud services are recovering from a recent widespread outage that impacted several major companies, including Starbucks and Lyft. This recovery is significant as it highlights the resilience of Amazon Web Services (AWS) and its importance in supporting various businesses. As AWS stabilizes, affected companies can resume their operations, ensuring minimal disruption to their services and customer experiences.
Air traffic controllers are becoming Uber drivers and restaurant servers on top of six-day airport shifts to make ends meet during government shutdown
NegativeFinancial Markets
Air traffic controllers are facing a tough situation as they continue to work during the government shutdown without pay. Many are taking on additional jobs as Uber drivers and restaurant servers to make ends meet. This highlights the challenges essential workers face when their livelihoods are threatened by political decisions, raising concerns about the impact on safety and morale in the aviation industry.
Gold Is Exploding Higher Again
PositiveFinancial Markets
Gold prices are surging again, capturing the attention of investors and market analysts alike. This rise is significant as it reflects broader trends in the economy and can influence various financial sectors. Understanding these movements is crucial for anyone involved in finance, as they can signal shifts in market sentiment and investment strategies.
Amazon battles to fix Web Services outage after millions of users report disruption to websites and apps – business live
NegativeFinancial Markets
Amazon is currently facing significant challenges as its Web Services experience a major outage, impacting millions of users and disrupting popular platforms like Fortnite, Roblox, and Snapchat. This situation is critical as it not only affects individual users but also businesses relying on these services for their operations. The outage highlights the vulnerabilities in cloud services and raises concerns about reliability, which could influence future investments and trust in such technologies.
Australia and US sign multi-billion dollar investment and defense deal
PositiveFinancial Markets
Australia and the United States have signed a significant multi-billion dollar investment and defense deal, marking a pivotal moment in their bilateral relations. This agreement not only strengthens military cooperation but also enhances economic ties, showcasing both nations' commitment to regional security and stability. The deal is expected to create jobs and boost technological advancements, making it a win-win for both countries.
Amazon is selling a $200 smartwatch for just $30
PositiveFinancial Markets
Amazon is offering a fantastic deal on a stylish and comfortable smartwatch, originally priced at $200, now available for just $30. This significant discount makes it an attractive option for tech enthusiasts and casual users alike, showcasing Amazon's commitment to providing affordable technology.